CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Authors
Dandona Paresh
et al.
+10 more
Griffen Steven C
Hansen Lars
Kollaboráció szervezet: DEPICT-1 Investigators
Langkilde Anna Maria
Mathieu Chantal
Phillip Moshe
Piros Györgyike Ágnes
Thorén Fredrik
Tschöpe Diethelm
Xu John
Publication date
1 January 2017
Publisher
'Elsevier BV'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
SZTE Publicatio Repozitórium - SZTE - Repository of Publications
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:publicatio.bibl.u-szeged.h...
Last time updated on 15/05/2023